JUL 30, 2020 2:21 PM PDT

Cats Successfully Treated with Gene Therapy

WRITTEN BY: Annie Lennon

While gene therapy is a promising treatment for multiple diseases caused by a genetic mutation, getting gene therapy agents beyond the brain-blood barrier- the brain's protective layer- is a challenge. Now, researchers from the University of Pennsylvania may have found a solution. 

Gene therapy works by delivering a functional version of a gene inside a virus- known as a viral vector- to a mutated version. In doing so, the functional version overrides the mutated version's effects and theoretically corrects the condition. While steady progress has been made in correcting neurogenetic diseases in rodents, applying the same treatments in larger mammals has only partially worked. 

In this new study, the researchers used cats to assess the efficacy of gene therapy to treat alpha-mannosidosis. The condition occurs naturally in cats from a mutated copy of the alpha-mannosidase gene. To assess whether their new gene therapy would work, they injected it into the cats' carotid artery for direct delivery to the brain. Cats either received a high or low dose of the vector. 

In the end, the researchers found that treated cats had a significantly delayed onset of certain neurological symptoms and a longer lifespan. They also noted that those on higher doses tended to live the longest. 

"It's a big advance," says John Wolfe, lead author of the study. "Nobody has been able to treat the whole brain of a large-brained animal before. We're hopeful that this will translate into clinical use in humans."

Although promising results, Wolfe cautions that the treatment did not cure the cats of their condition- although it did improve their symptoms. He added that they do not know whether the therapy impacted their mental ability. Thus, before any conclusions can be made about the treatment, further research is needed from more animal studies. 

 

Sources: Medical XpressOxford Academic

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
JUN 10, 2020
Drug Discovery & Development
Does Your Gut Microbiota Alter Drug Activity?
JUN 10, 2020
Does Your Gut Microbiota Alter Drug Activity?
Scientists have created a systematic way to evaluate how the microbial community in our gut influences drug behavior. Fi ...
JUN 17, 2020
Drug Discovery & Development
Treating Atherosclerosis
JUN 17, 2020
Treating Atherosclerosis
The two main proponents for atherosclerotic plaque and inflammation is an increase in cholesterol and macrophage presenc ...
JUN 30, 2020
Health & Medicine
UK Loosens Regulation on Prescription CBD for Epilepsy
JUN 30, 2020
UK Loosens Regulation on Prescription CBD for Epilepsy
Epidyolex-the epilepsy drug that contains the non-psychoactive cannabis chemical cannabidiol, or CBD-has been changed fr ...
JUL 13, 2020
Cannabis Sciences
Over Half of CBD Products Falsely Labeled
JUL 13, 2020
Over Half of CBD Products Falsely Labeled
Tests conducted by the US Food and Drug Agency (FDA) have found that 55% of cannabidiol (CBD) products contain significa ...
JUL 02, 2020
Drug Discovery & Development
Electrochemicals Fuel The Path for Drug Discovery
JUL 02, 2020
Electrochemicals Fuel The Path for Drug Discovery
Drug discovery scientists at Cornell University have diverted away from the traditional synthetic chemistry into a more ...
JUL 29, 2020
Drug Discovery & Development
Will We Have a COVID-19 Vaccine by Year-End?
JUL 29, 2020
Will We Have a COVID-19 Vaccine by Year-End?
This week, pharmaceutical companies Moderna and Pfizer launched giant Phase III 30,000-subject trials for their COVID-19 ...
Loading Comments...